Individuals who were 40-70 years old , overweight ( BMI 27-40 kg/m ( 2 ) ) and with prediabetes were randomised ( via a computerised system ) to receive liraglutide ( n = 35 ) or matching placebo ( n = 33 ) , and 49 participants were analysed .